India's Pharmaceutical Exports

Country Profile

Dominican Republic

Dominican Republic is a growing market for Indian pharmaceuticals — $88.1M in FY 2025–26, with 3.5× growth over the past decade. Medicines accounts for 91% of shipments, with vaccines contributing $1.26M. The compound annual growth rate since FY2016 stands at 13.3%.

🇩🇴 $88.1M · 3.5× growth since FY2016 · 13.3% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$88.1M
Exports FY2025–26 DGCIS
3.5×
Growth FY2016→2026
13.3%
CAGR FY2016→2026
91%
Medicines Share
5
Product Categories Supplied
Dominican Republic is a growing market for Indian pharmaceuticals — $88.1M in FY 2025–26, with 3.5× growth over the past decade. Medicines accounts for 91% of shipments, with vaccines contributing $1.26M. The compound annual growth rate since FY2016 stands at 13.3%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $80.2M (91.0%) Surgical & Hospital Supplies $3.37M (3.8%) Medicine Ingredients $3.17M (3.6%) Vaccines $1.26M (1.4%) Traditional & Herbal $97K (0.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Dominican Republic in the RBI overseas direct investment dataset (2011–2026).